Carna & OneThree Biotech Partnership Announcement
This webinar will be announcing the partnership between Carna Biosciences and OneThree Biotech. The OneThree Panel will be available through Carna and provide the opportunity to see drug similarity analysis and toxicity predictions.
All material presented in the webinar will be provided afterwards.
Submit Questions Below
Meet Our Presenters!
Dr. Akiko Futamura
Advisor, Former CEO Carna BioUSA
Akiko Futamura is a seasoned biotech executive and entrepreneur, and she is consultant and former CEO of CarnaBio USA. Akiko is known for her outstanding track record in leading the formation and management of numerous important US-Japan cross-borders partnerships in the pharmaceutical industry.
Brad Pryde
Co-Founder, COO
Brad brings a wealth of experience to OneThree which includes leading a tech start-up to acquisition as the CEO, building out tech-subdivisions from scratch for Fortune 500s as a Strategy Consultant, and much more.
Dr. Coryandar Gilvary
Co-Founder, CDO
Coryandar Gilvary obtained her PhD from Weill Cornell in record time (~ 3 years) and focused on developing new machine learning techniques for drug development. Cory leads OneThree’s data science and computational biology efforts and many of her early research projects helped form the core OneThree platform.
